Recurrent Angiosarcoma
2 clinical trials · Condition
◉ Watch Recurrent Angiosarcoma
| Record | Firm | Date |
|---|---|---|
| Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study (NCT05026736) | M.D. Anderson Cancer Center | 2021-08-23 |
| Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma (NCT04668300) | M.D. Anderson Cancer Center | 2020-11-26 |
Track Recurrent Angiosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.